Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.133 USD | +2.96% | +7.95% | -5.00% |
Business Summary
Number of employees: 53
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Abbreviated New Drug Applications
100.0
%
| 32 | 100.0 % | 34 | 100.0 % | +5.87% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 32 | 100.0 % | 34 | 100.0 % | +5.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01/13/01 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 01/09/01 |
Christopher Dick
PSD | President | 69 | 01/02/01 |
Douglas Plassche
COO | Chief Operating Officer | 61 | 12/13/12 |
Dianne Will
IRC | Investor Relations Contact | - | 01/03/01 |
Kirko Kirkov
PRN | Corporate Officer/Principal | 56 | 06/22/06 |
George Smith
LAW | General Counsel | - | 20/14/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 23/09/23 |
Barry Dash
BRD | Director/Board Member | 93 | 01/05/01 |
Davis Caskey
BRD | Director/Board Member | 76 | 28/16/28 |
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01/13/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,017,881,199 | 791,526,006 ( 77.76 %) | 100,000 ( 0.009824 %) | 77.76 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-5.00% | 138M | |
+19.98% | 43.67B | |
+20.67% | 22.51B | |
+13.93% | 14.6B | |
+14.32% | 13.74B | |
+44.72% | 11.91B | |
-8.37% | 7.04B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.42B |
- Stock Market
- Equities
- ELTP Stock
- Company Elite Pharmaceuticals, Inc.